Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer Interventions: Drug: Alectinib; Drug: Cetuximab; Drug: Crizotinib; Drug: Dasatinib; Drug: Everolimus; Drug: Encorafenib; Drug: Gemcitabine; Drug: Idelalisib; Drug: Larotrectinib; Drug: Methotrexate; Drug: Palbociclib; Drug: Panobinostat; Drug: Pembrolizumab; Drug: Petrozumab; Drug: Trastuzumab; Drug: Talazoparib; Drug: Venetoclax Sponsor: Oslo University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Erbitux | Herceptin | Hospitals | Methotrexate | Research | Study